- Home
- PHAR vs LDP Comparison
PHAR vs LDP Comparison
Compare PHAR & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- LDP
- Stock Information
- Founded
- PHAR 1988
- LDP 2012
- Country
- PHAR Netherlands
- LDP United States
- Employees
- PHAR N/A
- LDP N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- LDP Finance Companies
- Sector
- PHAR Health Care
- LDP Finance
- Exchange
- PHAR Nasdaq
- LDP Nasdaq
- Market Cap
- PHAR 679.0M
- LDP 599.3M
- IPO Year
- PHAR N/A
- LDP N/A
- Fundamental
- Price
- PHAR $9.10
- LDP $20.60
- Analyst Decision
- PHAR Strong Buy
- LDP
- Analyst Count
- PHAR 3
- LDP 0
- Target Price
- PHAR $27.00
- LDP N/A
- AVG Volume (30 Days)
- PHAR 6.7K
- LDP 102.5K
- Earning Date
- PHAR 03-13-2025
- LDP 01-01-0001
- Dividend Yield
- PHAR N/A
- LDP 7.91%
- EPS Growth
- PHAR N/A
- LDP N/A
- EPS
- PHAR N/A
- LDP N/A
- Revenue
- PHAR $285,745,000.00
- LDP N/A
- Revenue This Year
- PHAR $20.08
- LDP N/A
- Revenue Next Year
- PHAR $9.22
- LDP N/A
- P/E Ratio
- PHAR N/A
- LDP N/A
- Revenue Growth
- PHAR 30.64
- LDP N/A
- 52 Week Low
- PHAR $6.65
- LDP $16.16
- 52 Week High
- PHAR $13.20
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- PHAR 46.44
- LDP 53.49
- Support Level
- PHAR $9.37
- LDP $20.11
- Resistance Level
- PHAR $10.01
- LDP $20.63
- Average True Range (ATR)
- PHAR 0.55
- LDP 0.23
- MACD
- PHAR -0.14
- LDP 0.06
- Stochastic Oscillator
- PHAR 16.26
- LDP 90.07
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.